BRTX — Biorestorative Therapies Share News
0.000.00%
Last trade - 00:00- $2.24m
- -$1.35m
- $0.36m
U.S. STOCKS ON THE MOVE-AerCap, Burlington Stores, Salesforce
U.S. STOCKS ON THE MOVE-Apple Inc, Tesla, Best Buy
BioRestorative Therapies rises on U.S. patent for obesity therapy
Brief: Biorestorative Therapies Receives Notice Of Allowance By The United States Patent And Trademark Office For A Patent Application Related To Its Thermostem® Program
Brief: BioRestorative Therapies Announces Notice Of Allowance By European Patent Office For Patent Related To Its ThermoStem Program
Brief: BioRestorative Therapies Inc Files For Mixed Shelf Of Up To $75 Million – SEC Filing
Brief: BioRestorative Therapies Announces SBIR Phase I Grant To Explore The Therapeutic Effects Of ThermoStem Targeting Polycystic Ovary Syndrome As Indication
U.S. STOCKS ON THE MOVE-TFF Pharma, BioRestorative,
BioRestorative up on license rights agreement for spinal disease therapy
Brief: Biorestorative Therapies Enters Into Agreement With Regenexx
U.S. STOCKS ON THE MOVE-Heartbeam, Aura Biosciences, U.S. banks
BioRestorative Therapies up as Maxim initiates coverage with 'buy' rating
Brief: BioRestorative Therapies Announces First Patient Enrolled For The Company’s Phase 2 Clinical Trial To Treat Chronic Lumbar Disc Disease (CLDD)
Brief: BioRestorative Announces Clinical Trial Contract With Second Site For Phase 2 Clinical Trial To Treat CLDD
Brief: Biorestorative Therapies Announces Clinical Site Initiation For Co's Phase 2 Clinical Trial To Treat Chronic Lumbar Disc Disease
Brief: Biorestorative Therapies Inc Files For Stock Shelf Of Up To 1.9 Million By Selling Securityholders - SEC Filing
Brief: BioRestorative Therapies Hosts Principal Investigator Meeting for BRTX-100 Trial
Brief: BioRestorative Selects 10 Clinical Sites For Phase 2 Clinical Trial To Treat Chronic Lumbar Disc Disease
Brief: Biorestorative Therapies Announces Research Collaboration With Professor Tore Bengtsson To Evaluate Heat Production Of Its Thermostem® Program